Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative
By leveraging the PCP approach, OncNGS aims to deliver innovative, affordable solutions to standardize ctDNA testing and reporting across European Union countries, improving diagnostic and therapeutic strategies for oncology patients.
Authors
- A. Alay
- Thomas Delcourt (ORCID: https://orcid.org/0000-0003-1690-1957)
- Aline Hébrant
- Steven Van Garsse (ORCID: https://orcid.org/0000-0002-3412-2714)
- Marie Delnord (ORCID: https://orcid.org/0000-0002-3168-0219)
- Sylvie Huet
- Pierre Sujobert (ORCID: https://orcid.org/0000-0002-9108-1162)
- Valentina Trapani (ORCID: https://orcid.org/0000-0002-0259-6624)
- Rossana Alessandrello (ORCID: https://orcid.org/0000-0001-7808-5268)
- Lars Bullinger (ORCID: https://orcid.org/0000-0002-5890-5510)
- Luca Mazzarella (ORCID: https://orcid.org/0000-0002-4043-3279)
- Gianmaria Frigè (ORCID: https://orcid.org/0000-0003-3253-7091)
- José Miguel Cuevas Gonzalo
- A Michalík
- Maud Kamal (ORCID: https://orcid.org/0000-0003-1466-0950)
- A. Krol
- M. Gausachs
- Patrizio Giacomini (ORCID: https://orcid.org/0000-0001-6109-1709)
- Claude Van Campenhout (ORCID: https://orcid.org/0000-0001-6859-1087)
- David Cordero (ORCID: https://orcid.org/0000-0003-1470-2356)
- Olga Blau (ORCID: https://orcid.org/0000-0002-4304-5079)
- Jerry García
- Eulàlia de Nadal (ORCID: https://orcid.org/0000-0003-0039-5607)
- Philippe Aftimos (ORCID: https://orcid.org/0000-0001-9946-4726)
- Célia Dupain (ORCID: https://orcid.org/0000-0001-6248-140X)
- Marc Van den Bulcke (ORCID: https://orcid.org/0000-0002-1866-154X)
- Gordana Raicevic Toungouz (ORCID: https://orcid.org/0000-0002-2934-0426)
- Nadège Servant
- R. Carbone
- H Antoine-Poirel
- M R Mias Carballal
- E Silkenstedt
- C Codony
- N Van Damme
- N D'Haene
Institutions
- Inserm (FR)
- Institut Jules Bordet (BE)
- Institut Gustave Roussy (FR)
- Agostino Gemelli University Polyclinic (IT)
- Custodix (Belgium) (BE)
- Saint Camillus International University of Health and Medical Sciences (IT)
- Hospices Civils de Lyon (FR)
- Institut Català d'Oncologia (ES)
- Province of Antwerp (BE)
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (ES)
- Sciensano (Belgium) (BE)
- Institut National du Cancer (FR)
- International Drug Development (FR)
- Vall d'Hebron Institute of Oncology (ES)
- European Institute of Oncology (IT)
- Charité - Universitätsmedizin Berlin (DE)
- Institut Curie (FR)
- Ludwig-Maximilians-Universität München (DE)
- HCL Technologies (India) (IN)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105127
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- MacroGenics
- G1 Therapeutics
- European Commission
- Servier
- Horizon 2020 Framework Programme
- Daiichi Sankyo Europe